|
Response rates by country and proportions of the patients prescribed desferrioxamine from each country |
|||||||||||
| Country |
CY |
EG |
GR |
HK |
IN |
IR |
IT |
JO |
TA |
US |
Total |
|
|
|||||||||||
| Membership |
636 |
2,801 |
922 |
334 |
823 |
6,810 |
840 |
360 |
302 |
310 |
14,138 |
|
|
|||||||||||
| Questionnaires dispatched |
300 |
300 |
200 |
300 |
300 |
300 |
300 |
300 |
300 |
300 |
2,900 |
| Questionnaires completed |
275 |
199 |
118 |
159 |
235 |
215 |
147 |
232 |
231 |
77 |
1,888 |
| Response rate (%) |
92 |
66 |
59 |
53 |
78 |
72 |
49 |
77 |
77 |
26 |
65 |
| Desferrioxamine use, N (%) |
267 (97) |
120 (60) |
112 (95) |
147 (93) |
128 (55) |
200 (93) |
132 (90) |
185 (80) |
212 (92) |
70 (91) |
1573 (83) |
|
Cyprus (CY), Egypt (EG), Greece (GR), Hong Kong (HK), India (IN), Iran (IR), Italy (IT), Jordan (JO), Taiwan (TA), United States (US) | |||||||||||
Ward et al. BMC Clinical Pharmacology 2002 2:3 doi:10.1186/1472-6904-2-3 |
|||||||||||